Navigation Links
Simbionix Launches Innovative Patient-Specific Simulation
Date:10/3/2008

CLEVELAND, Ohio, October 3 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, advances procedural simulation from theoretical promise to operating room reality.

The PROcedure Rehearsal Studio(TM), Simbionix' latest innovative medical simulation system, is the world's first medical simulator that enables clinicians to create practice scenarios based on their patient's unique pathology and anatomy.

Dr. Karl Illig, Chief of Vascular Surgery at Strong Medical Center in Rochester, NY, explains why physicians are eager to start using the new simulator: "PROcedure Studio helps us identify pitfalls and problems and solve them on the machine. If we're going to make a mistake, let's make it on the simulators first."

Gary Zamler, CEO of Simbionix, sees the launch of Procedure as "a quantum leap in the world of medical simulation that has the potential to significantly improve patient outcomes while reducing health care costs."

"Our leading technology has made Simbionix the industry leader in medical simulation. PROcedure Rehearsal Studio shows where that leadership will be taking everyone."

Mr. Zamler also announced that Strong Medical Center in Rochester, NY, Imperial College, UK, and Sheba Hospital, Israel have already signed agreements with Simbionix to use PROcedure Rehearsal Studio in their simulation centers.

"These leading hospitals will use and test PROcedure Rehearsal Studio in accordance with Simbionix' philosophy and mission to collaborate with the medical community developing leading-edge technologies for training and education while promoting patient safety."

Simbionix will unveil this next generation of medical simulation on October 12th at the Annual Transcatheter Cardiovascular Therapeutic symposium (TCT) in Washington, DC.

Company Description

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures.
http://www.simbionix.com

Contact:

Inbal Mazor

VP Marketing

Simbionix

inbal@simbionix.com

Tel: +972-8-9211177


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
2. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
3. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
4. CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
5. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
6. Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
7. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
8. Lena Chow, Veteran Biotech Marketer, Launches New Website
9. BioSpace Launches Life Science Career Content and Resources from the Biotech Work Portal
10. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
11. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of ... Assay from Salimetrics’ SalivaLab , the relationship between insulin and other relevant ...
(Date:2/23/2017)... SAN DIEGO and SAN FRANCISCO ... , a privately-held regenerative medicine company, and Beyond Type ... living with type 1 diabetes, today announced a grant ... develop a functional cure for type 1 and other ... decade, ViaCyte has been developing innovative stem cell-derived cell ...
(Date:2/22/2017)... ... February 22, 2017 , ... Park Systems , a leader in Atomic ... all SPIE attendees and Park customers on Feb. 27, 2017 from 12-2pm ... Jose Convention Center. The luncheon will feature a talk on Automated AFM for ...
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences (“ProMIS” or ... neurodegenerative diseases, today announced it has issued a scientific white paper entitled “Results ... a series of commentaries from ProMIS’s scientific team offering insight into the Company’s ...
Breaking Biology Technology:
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
(Date:1/26/2017)... 26, 2017  Acuity Market Intelligence today released ... Digital Identity".  Acuity characterizes 2017 as a "breakout" ... adoption reflects a new understanding of the potential ... and digital identity are often perceived as threats ... , Principal of Acuity Market intelligence. "However, taken ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
Breaking Biology News(10 mins):